Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Abliva AB (publ) (F: NTP)

 
NTP Technical Analysis
5
As on 23rd Dec 2024 NTP STOCK Price closed @ 0.04 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.01 & Strong Buy for SHORT-TERM with Stoploss of 0.01 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NTPSTOCK Price

Open 0.03 Change Price %
High 0.04 1 Day 0.00 0.00
Low 0.03 1 Week 0.03 300.00
Close 0.04 1 Month 0.03 238.25
Volume 7000 1 Year 0.03 300.00
52 Week High 0.04 | 52 Week Low 0.00
 
F Germany Most Active Stocks
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
 
F Germany Top Gainers Stocks
JYR 1000000.00 10000000000.00%
JYR 1000000.00 10000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
HGF2 7.40 1380.00%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
LDB 1.71 -92.57%
 
 
NTP
Daily Charts		 NTP
Intraday Charts		 Whats New @
Bazaartrend		 NTP
Free Analysis
 
NTP Important Levels Intraday
RESISTANCE0.06
RESISTANCE0.05
RESISTANCE0.05
RESISTANCE0.05
SUPPORT0.03
SUPPORT0.03
SUPPORT0.03
SUPPORT0.02
 
NTP Forecast December 2024
Share
4th UP Forecast0.08
3rd UP Forecast0.07
2nd UP Forecast0.06
1st UP Forecast0.05
1st DOWN Forecast0.03
2nd DOWN Forecast0.02
3rd DOWN Forecast0.01
4th DOWN Forecast0
 
NTP Weekly Forecast
4th UP Forecast0.08
3rd UP Forecast0.07
2nd UP Forecast0.06
1st UP Forecast0.05
1st DOWN Forecast0.03
2nd DOWN Forecast0.02
3rd DOWN Forecast0.01
4th DOWN Forecast0.00
 
NTP Forecast2024
4th UP Forecast0.12
3rd UP Forecast0.09
2nd UP Forecast0.08
1st UP Forecast0.06
1st DOWN Forecast0.02
2nd DOWN Forecast0
3rd DOWN Forecast-0.01
4th DOWN Forecast-0.04
 
 
NTP Other Details
Segment EQ
Market Capital 21362054.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NTP Address
NTP
 
NTP Latest News
 
Your Comments and Response on Abliva AB (publ)
 
NTP Business Profile
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden. Address: Medicon Village, Lund, Sweden, 223 81
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service